COGNITIVE FUNCTION AND REGIONAL CEREBRAL BLOOD-FLOW IN PARKINSONS-DISEASE

被引:78
|
作者
JAGUST, WJ [1 ]
REED, BR [1 ]
MARTIN, EM [1 ]
EBERLING, JL [1 ]
NELSONABBOTT, RA [1 ]
机构
[1] UNIV CALIF DAVIS,DEPT NEUROL,DAVIS,CA 95616
关键词
D O I
10.1093/brain/115.2.521
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In order to investigate relationships between cognition and regional brain function, we studied 20 non-demented patients with idiopathic Parkinson's disease (PD), 21 mildly demented patients with Alzheimer's disease (AD) and 24 control subjects using cognitive testing and single photon emission computerized tomographic (SPECT) measurements of relative regional cerebral blood flow (rCBF). Neuro-psychological tests were grouped into clusters reflecting frontal lobe executive abilities, perseveration, memory and visuospatial ability, with a summary score summarizing performance in all four of these spheres. SPECT imaging utilized the tracer [I-123]N-isopropyl-p-iodoamphetamine with a relative measure of regional tracer uptake normalized to occipital radiotracer uptake (rCBF ratios). Patients with PD performed more poorly than controls in all cognitive domains, and were intermediate to AD patients and controls in tests of memory and overall cognitive functioning. Those PD patients who performed most poorly on neuro-psychological testing showed lowest rCBF ratios in left and right temporal lobes, Using a stepwise multiple regression procedure, we examined patterns of correlations between cognitive clusters and predictor variables, including rCBF ratios, in the PD patients. We found that while patient age was a strong determinant of performance on the memory cluster and the summary score, dorsolateral frontal lobe perfusion and scores on a depression inventory accounted for a greater proportion of the variance of the frontal lobe and perseveration clusters than did age. These results imply that different neural mechanisms are responsible for the different aspects of cognitive decline seen in PD patients, with overall cognitive function closely related to age and temporal perfusion, while frontal lobe abilities are more linked to frontal perfusion and the presence of depression.
引用
收藏
页码:521 / 537
页数:17
相关论文
共 50 条
  • [1] REGIONAL CEREBRAL BLOOD-FLOW IN PATIENTS WITH PARKINSONS-DISEASE
    LAVY, S
    MELAMED, E
    COOPER, G
    BENTIN, S
    RINOT, Y
    ARCHIVES OF NEUROLOGY, 1979, 36 (06) : 344 - 348
  • [2] CEREBRAL BLOOD-FLOW AND COGNITIVE IMPAIRMENT IN PARKINSONS-DISEASE
    GLOBUS, M
    MILDWORF, B
    MELAMED, E
    NEUROLOGY, 1985, 35 (08) : 1135 - 1139
  • [3] REDUCTION OF THE REGIONAL CEREBRAL BLOOD-FLOW IN PATIENTS WITH PARKINSONS-DISEASE
    LAVY, S
    MELAMED, E
    COOPER, G
    BENTIN, S
    RINOT, Y
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 294 - 294
  • [4] CEREBRAL BLOOD-FLOW AND DEMENTIA IN PARKINSONS-DISEASE
    KAWABATA, K
    TACHIBANA, H
    TSUCHIYAMA, M
    SUGITA, M
    NEUROBIOLOGY OF AGING, 1990, 11 (03) : 265 - 266
  • [5] ALTERATIONS OF REGIONAL CEREBRAL BLOOD-FLOW AND OXYGEN-METABOLISM IN PARKINSONS-DISEASE
    WOLFSON, LI
    LEENDERS, KL
    BROWN, LL
    JONES, T
    NEUROLOGY, 1985, 35 (10) : 1399 - 1405
  • [6] REGIONAL CEREBRAL BLOOD-FLOW IN PATIENTS WITH PARKINSONS-DISEASE - EFFECTS OF DOPAMINERGIC AGONISTS
    MARCVERGNES, JP
    CELSIS, P
    MONTASTRUC, JL
    DEMONET, JF
    AGNIEL, A
    RASCOL, O
    VIALLARD, G
    DOYON, B
    RASCOL, A
    THERAPIE, 1988, 43 (02): : 83 - 88
  • [7] TOMOGRAPHIC MEASUREMENTS OF REGIONAL CEREBRAL BLOOD-FLOW IN PROGRESSIVE SUPRANUCLEAR PALSY AND PARKINSONS-DISEASE
    DEFEBVRE, L
    LECOUFFE, P
    DESTEE, A
    HOUDART, P
    STEINLING, M
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 92 (03): : 235 - 241
  • [8] EFFECT OF TROPATEPINE, AN ANTICHOLINERGIC DRUG, ON REGIONAL CEREBRAL BLOOD-FLOW IN PATIENTS WITH PARKINSONS-DISEASE
    CELSIS, P
    MONTASTRUC, JL
    RASCOL, O
    SENARD, JM
    MARCVERGNES, JP
    RASCOL, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (07): : 917 - 918
  • [9] CHANGES IN CEREBRAL BLOOD-FLOW INDUCED BY BROMOCRIPTINE IN PARKINSONS-DISEASE
    CELSIS, P
    RASCOL, O
    DEMONET, JF
    AGNIEL, A
    MONTASTRUC, JL
    MARCVERGNES, JP
    RASCOL, A
    REVUE NEUROLOGIQUE, 1988, 144 (05) : 367 - 371
  • [10] EFFECTS OF APOMORPHINE ON CEREBRAL BLOOD-FLOW AND EXTRAPYRAMIDAL SYMPTOMS IN PARKINSONS-DISEASE
    SABATINI, U
    RASCOL, O
    CELSIS, P
    MARCVERGNES, JP
    MONTASTRUC, JL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (02) : 532 - 533